These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 12019098
21. Multifunctional Acidocin 4356 Combats Pseudomonas aeruginosa through Membrane Perturbation and Virulence Attenuation: Experimental Results Confirm Molecular Dynamics Simulation. Modiri S, Kasra Kermanshahi R, Soudi MR, Arab SS, Khammari A, Cousineau B, Vali H, Zahiri HS, Noghabi KA. Appl Environ Microbiol; 2020 May 05; 86(10):. PubMed ID: 32169940 [Abstract] [Full Text] [Related]
22. Antibacterial properties of dermaseptin S4 derivatives with in vivo activity. Navon-Venezia S, Feder R, Gaidukov L, Carmeli Y, Mor A. Antimicrob Agents Chemother; 2002 Mar 05; 46(3):689-94. PubMed ID: 11850249 [Abstract] [Full Text] [Related]
23. The efficacy of honey in inhibiting strains of Pseudomonas aeruginosa from infected burns. Cooper RA, Halas E, Molan PC. J Burn Care Rehabil; 2002 Mar 05; 23(6):366-70. PubMed ID: 12432313 [Abstract] [Full Text] [Related]
24. A novel antimicrobial peptide Scyreptin1-30 from Scylla paramamosain exhibiting potential therapy of Pseudomonas aeruginosa early infection in a mouse burn wound model. Zhang W, An Z, Bai Y, Zhou Y, Chen F, Wang KJ. Biochem Pharmacol; 2023 Dec 05; 218():115917. PubMed ID: 37952897 [Abstract] [Full Text] [Related]
25. Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. Cirioni O, Giacometti A, Ghiselli R, Orlando F, Kamysz W, D'Amato G, Mocchegiani F, Lukasiak J, Silvestri C, Saba V, Scalise G. J Infect Dis; 2004 Jul 15; 190(2):356-64. PubMed ID: 15216473 [Abstract] [Full Text] [Related]
26. Design of novispirin antimicrobial peptides by quantitative structure-activity relationship. Taboureau O, Olsen OH, Nielsen JD, Raventos D, Mygind PH, Kristensen HH. Chem Biol Drug Des; 2006 Jul 15; 68(1):48-57. PubMed ID: 16923026 [Abstract] [Full Text] [Related]
27. Structural features governing the activity of lactoferricin-derived peptides that act in synergy with antibiotics against Pseudomonas aeruginosa in vitro and in vivo. Sánchez-Gómez S, Japelj B, Jerala R, Moriyón I, Fernández Alonso M, Leiva J, Blondelle SE, Andrä J, Brandenburg K, Lohner K, Martínez de Tejada G. Antimicrob Agents Chemother; 2011 Jan 15; 55(1):218-28. PubMed ID: 20956602 [Abstract] [Full Text] [Related]
31. Membrane-active peptide PV3 efficiently eradicates multidrug-resistant Pseudomonas aeruginosa in a mouse model of burn infection. Memariani H, Shahbazzadeh D, Sabatier JM, Pooshang Bagheri K. APMIS; 2018 Feb 15; 126(2):114-122. PubMed ID: 29327480 [Abstract] [Full Text] [Related]
32. Highly Synergistic Effects of Melittin with Conventional Antibiotics Against Multidrug-Resistant Isolates of Acinetobacter baumannii and Pseudomonas aeruginosa. Akbari R, Hakemi-Vala M, Pashaie F, Bevalian P, Hashemi A, Pooshang Bagheri K. Microb Drug Resist; 2019 Mar 15; 25(2):193-202. PubMed ID: 30281385 [Abstract] [Full Text] [Related]
33. In vitro and in vivo antimicrobial activity of a synthetic peptide derived from the C-terminal region of human chemokine CCL13 against Pseudomonas aeruginosa. Cossio-Ayala M, Domínguez-López M, Mendez-Enriquez E, Portillo-Téllez MDC, García-Hernández E. Peptides; 2017 Aug 15; 94():49-55. PubMed ID: 28687455 [Abstract] [Full Text] [Related]
34. Antibacterial and anti-inflammatory activity of a temporin B peptide analogue on an in vitro model of cystic fibrosis. Bezzerri V, Avitabile C, Dechecchi MC, Lampronti I, Borgatti M, Montagner G, Cabrini G, Gambari R, Romanelli A. J Pept Sci; 2014 Oct 15; 20(10):822-30. PubMed ID: 25201563 [Abstract] [Full Text] [Related]
35. Antimicrobial photodynamic therapy on drug-resistant Pseudomonas aeruginosa-induced infection. An in vivo study. Hashimoto MC, Prates RA, Kato IT, Núñez SC, Courrol LC, Ribeiro MS. Photochem Photobiol; 2012 Oct 15; 88(3):590-5. PubMed ID: 22404212 [Abstract] [Full Text] [Related]
36. Tryptophan end-tagging of antimicrobial peptides for increased potency against Pseudomonas aeruginosa. Pasupuleti M, Chalupka A, Mörgelin M, Schmidtchen A, Malmsten M. Biochim Biophys Acta; 2009 Aug 15; 1790(8):800-8. PubMed ID: 19345721 [Abstract] [Full Text] [Related]
37. Diversity of virulence genes in multidrug resistant Pseudomonas aeruginosa isolated from burn wound infections. Haghi F, Zeighami H, Monazami A, Toutouchi F, Nazaralian S, Naderi G. Microb Pathog; 2018 Feb 15; 115():251-256. PubMed ID: 29273509 [Abstract] [Full Text] [Related]
38. Adding selectivity to antimicrobial peptides: rational design of a multidomain peptide against Pseudomonas spp. Eckert R, Qi F, Yarbrough DK, He J, Anderson MH, Shi W. Antimicrob Agents Chemother; 2006 Apr 15; 50(4):1480-8. PubMed ID: 16569868 [Abstract] [Full Text] [Related]
39. Comparative diffusion assay to assess efficacy of topical antimicrobial agents against Pseudomonas aeruginosa in burns care. Aujoulat F, Lebreton F, Romano S, Delage M, Marchandin H, Brabet M, Bricard F, Godreuil S, Parer S, Jumas-Bilak E. Ann Clin Microbiol Antimicrob; 2011 Jun 24; 10():27. PubMed ID: 21702921 [Abstract] [Full Text] [Related]
40. Antimicrobial Activity and Cell Selectivity of Synthetic and Biosynthetic Cationic Polymers. Venkatesh M, Barathi VA, Goh ETL, Anggara R, Fazil MHUT, Ng AJY, Harini S, Aung TT, Fox SJ, Liu S, Yang L, Barkham TMS, Loh XJ, Verma NK, Beuerman RW, Lakshminarayanan R. Antimicrob Agents Chemother; 2017 Oct 24; 61(10):. PubMed ID: 28784676 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]